Inhibitors of hepatitis C virus NS3 protease

The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associ...

Full description

Saved in:
Bibliographic Details
Main Authors Bogen, Stephane L, Pan, Weidong, Ruan, Sumei, Chen, Kevin X, Arasappan, Ashok, Venkatraman, Srikanth, Nair, Latha G, Sannigrahi, Mousumi, Bennett, Frank, Saksena, Anil K, Njoroge, F. George, Girijavallabhan, Viyyoor M
Format Patent
LanguageEnglish
Published 09.09.2008
Online AccessGet full text

Cover

More Information
Summary:The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.